Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica

Raphael P. Viscidi, Mark Schiffman, Allan Hildesheim, Rolando Herrero, Philip E. Castle, Maria C. Bratti, Ana Cecilia Rodriguez, Mark E. Sherman, Sophia Wang, Barbara Clayman, Robert D. Burk

Research output: Contribution to journalArticlepeer-review

161 Scopus citations

Fingerprint Dive into the research topics of 'Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica'. Together they form a unique fingerprint.

Medicine & Life Sciences